The Ontario Physicians and Surgeons Discipline Tribunal ruled Jan. 28 that Ashwin Rajan Maharaj demonstrated incompetence and engaged in disgraceful, dishonourable and unprofessional conduct in his ...

Economist Ludwig von Mises famously described economics as the study of human activity in a world of limited resources and unlimited wants. Central to his thinking was the idea that individuals must ...

"Compound interest is the eighth wonder of the world. He who understands it, earns it. He who doesn't, pays it." Albert Einstein is often credited with coining this famous saying, despite a lack of ...

Sterile compounding has long been recognized as a high-risk area of health system pharmacy. Traditional manual IV compounding techniques can be prone to human error, leading to incorrect ingredients ...

The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications. The market for drugs that treat obesity and help people lose weight is soaring.

A compounding pharmacy in Amherst is in trouble with the law after hiring a third-party company to help get prescriptions approved by insurers, including Medicare, with many of them allegedly being ...

Still life of Ozempic and Wegovy. Both are injectable prescription weight loss medicines. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) As demand surges for semaglutide ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Novo Nordisk is ending a ...

The surge in demand for GLP-1 medicines has led to a market made up of compounded versions sold online. While compounding pharmacies are essential for patients who can’t medically tolerate ...

In a Q&A with Pharma Commerce, Kurt Lunkwitz, ProRx Pharma’s COO, uncovers the stringent requirements that 503B outsourcing facilities must abide by under the Drug Quality and Security Act, while also ...

The S&P 500 index has yielded a 220% return in the last 10 years. Peter Mallouk, the CEO of Creative Planning Inc., highlights this data and recalls veteran investor Charlie Munger‘s insights on the ...